G9a-IN-3
G9a-IN-3 (compound 16g) is a potent G9a inhibitor with an IC50 of 0.002 μM. G9a-IN-3 can be used in the study of sickle cell disease[1].
Product Specifications
UNSPSC
12352211
Target
Histone Methyltransferase
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer; Cardiovascular Disease
Smiles
O=C(N[C@H](C(NC1=CN=C(OCC)C=C1)=O)CCC2CC2)C3=CC=C(NC4=CC=NC=C4)C=C3
Molecular Formula
C26H29N5O3
Molecular Weight
459.54
References & Citations
[1]Nishigaya Y, et al. Discovery of potent substrate-type lysine methyltransferase G9a inhibitors for the treatment of sickle cell disease. Eur J Med Chem. 2025 May 11;293:117721.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E51P00624 100 µg
TROP-2/TACSTD2 Protein, Human, Recombinant (C-His-Avi), Biotinylated
Ask
View Details 
MBS1264294-01 0.05 mg (E-Coli)
Recombinant Human AT-rich interactive domain-containing protein 1A (ARID1A) , partial
Ask
View Details 
MBS1264294-02 0.05 mg (Yeast)
Recombinant Human AT-rich interactive domain-containing protein 1A (ARID1A) , partial
Ask
View Details 
MBS1264294-03 0.2 mg (E-Coli)
Recombinant Human AT-rich interactive domain-containing protein 1A (ARID1A) , partial
Ask
View Details MBS1264294-04 0.5 mg (E-Coli)
Recombinant Human AT-rich interactive domain-containing protein 1A (ARID1A) , partial
Ask
View Details MBS1264294-05 0.05 mg (Baculovirus)
Recombinant Human AT-rich interactive domain-containing protein 1A (ARID1A) , partial
Ask
View Details